Study comparing the effect of crizanlizumab plus standard of care to standard of care alone on renal function in sickle cell disease patients,with chronic kidney disease due to sickle cell nephropathy (STEADFAST).

Study comparing the effect of crizanlizumab plus standard of care to standard of care alone on renal function in sickle cell disease patients,with chronic kidney disease due to sickle cell nephropathy (STEADFAST).
Recruiting
16 years - 99 years
All
Phase 2
2 participants needed
1 Location

Brief description of study

The main purpose of the study is to explore the effect of crizanlizumab on kidney function in people with long-term kidney disease caused by SCD. Kidney function of patients who receive crizanlizumab in addition to any regularly prescribed medications will be compared to that of patients who receive their regularly prescribed medications but do not receive crizanlizumab.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: sickle cell nephropathy,chronic kidney disease
  • Age: 16 years - 99 years
  • Gender: All

Male and Female Age `16 and older kidney disease caused by Sickle Cell

Updated on 04 Aug 2024. Study ID: 849407

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center